Yahoo

FDA urges maker to recall Limbrel after liver and lung injury reports

The FDA lifted a clinical hold on Sarepta’s early-stage clinical trial for a gene therapy for Duchenne muscular dystrophy, putting the company's plans back on schedule. The Food and Drug ...
Becker's Hospital Review

Primus Pharma halts production, marketing of Limbrel in response to FDA safety concerns

Scottsdale, Ariz.-based Primus Pharmaceuticals took its osteoarthritis treatment Limbrel off the market at the FDA’s request, according to azcentral. While Primus markets Limbrel as a medical food, ...
Monthly Prescribing Reference

FDA: Potentially Life-Threatening Adverse Events Linked to Limbrel

The FDA is continuing to investigate Primus Pharmaceuticals and the manufacturing process for Limbrel, and will share updates as they become available. The Food and Drug Administration (FDA) has ...
Capitalbolsa

Primus Announces A Voluntary Nationwide Recall Of All Lots Within Expiry Of Prescription Medical Food Limbrel® Due To Rare But Serious And Reversible Adverse Events While ...

SCOTTSDALE, Ariz., Jan. 26, 2018 /PRNewswire/ -- Primus Pharmaceuticals, Inc. of Scottsdale, Arizona is voluntarily recalling all unexpired lots of Limbrel products to the patient (user/consumer) ...